Purpose

The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 60 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • symptomatic vasovagal syncope or symptomatic bradyarrhythmia refractory to behavioral and medical measures - age < 60 years

Exclusion Criteria

  • age > 60 years - intra-/infra-Hisian AV block - intrinsic sinus node disease - history of supraventricular tachycardia - history of ventricular tachycardia - presence of structural heart disease related - prior history of catheter ablation - presence of inheritable arrhythmic conditions - orthostatic hypotension on HUTT test - abnormal thyroid function levels - Proven indication for permanent pacemaker implantation

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Case-Crossover
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Control group Awaiting the intervention, medically managed patients will remain in the control group for analysis purposes
Procedural group After undergoing successful radiofrequency cardioneuroablation or permanent pacemaker procedures the patient will cross-over to the procedural group for analysis purposes
  • Procedure: Ablation procedure
    Cardioneuroablation procedure or permanent pacemaker placement
    Other names:
    • Permanent pacemaker placement

Recruiting Locations

Rush University Medical Centert
Chicago, Illinois 60657
Contact:
Henry D Huang, MD
312-942-5020
henry_d_huang@rush.edu

More Details

NCT ID
NCT06166277
Status
Recruiting
Sponsor
Rush University Medical Center

Study Contact

Henry Huang, MD
972-951-5317
henry_d_huang@rush.edu

Detailed Description

The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation. Major inclusion criteria for enrollment are history of VVS or symptomatic bradyarrhythmia, age < 60 years, and evaluation by a physician and discussion about potential candidacy for radiofrequency cardioneuroablation or permanent pacemaker implantation for medically refractory symptoms. For analysis purposes, patients awaiting the intervention will remain in the "control group" and will cross-over to the "procedural group" after successful completion of radiofrequency cardioneuroablation procedure. The follow-up for the procedure group will start at completion of CNA procedure, but patients who eventually do not get the procedure will stay in the control group until the end of the study, with similar follow-up performed as for the patients undergoing RFCA procedure. If a patient in the control group undergoes permanent pacemaker placement, then the day after the procedure the patient will be removed from the control group for follow up.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.